Viromed Medical AG, a medical technology company specializing in cold plasma technology, announced the appointment of Prof. Dr. Michael A. Rubhausen to its Medical Advisory Board, effective immediately. The physicist and expert in spectroscopy brings scientific expertise in spectroscopy and materials research to guide the company's research efforts.
Uwe Perbandt, CEO of Viromed Medical AG, stated: 'With Prof. Dr. Michael A. Rubhausen, we are gaining a proven expert in modern spectroscopy and materials research for our Medical Advisory Board. His expertise is intended to help us thoroughly evaluate scientific questions at the intersection of material properties, spectroscopy, and cold plasma, and support our further research work.' This appointment underscores the company's commitment to advancing cold plasma technology in medical applications.
Prof. Dr. Rubhausen heads the Optics Working Group at the Institute of Nanostructure and Solid-State Physics at Universität Hamburg and serves as the Institute's Managing Director. He is also affiliated with the Center for Free-Electron Laser Science (CFEL). His research focuses on modern spectroscopic methods, including Raman spectroscopy and ellipsometry, which he applies to study superconductors, quantum materials, and biological samples at large-scale research facilities such as PETRA III and FLASH. His interdisciplinary work has resulted in over 180 publications with approximately 4,000 citations in prestigious journals, including Physical Review Letters, JACS, Angewandte Chemie, Nature Chemistry, Nature Physics, and Nature Communications. Additionally, he develops AI-supported analysis workflows for complex datasets.
Viromed Medical AG specializes in the development, manufacture, and distribution of medical products. Listed on the stock exchange since October 2022, the company focuses on the distribution of innovative cold plasma technology through its wholly owned subsidiary, Viromed Medical GmbH. With a broad customer base in the DACH region, Viromed aims to further advance the use of cold plasma in medicine and realize growth potential. For more information, visit Viromed Medical AG.
